Clinical Trials Sponsored by Medix Farma

Total 453 results

MEDEX

Unknown

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients

Hiv Infection With Antiretroviral Therapy Indication | CD4 Below 350/µL or Below 15%

France
Hospital General de México Dr. Eduardo Liceaga
National Polytechnic Institute, Mexico; Italmex Pharma; Medix Farma

Unknown

Probiotics on Body Composition and Insulin Resistance in Patients With Obesity and Its Association With Gut Microbiota

Obesity | Insulin Resistance | Microbial Colonization

Mexico
Kocak Farma

Recruiting

Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo

COVID-19 Vaccine

Turkey
Aelis Farma

Completed

Study of [4-14C] AEF0117 Following a Single Oral Dose in Healthy Male Subjects

Marijuana Abuse

United States
Mebix Inc

Unknown

The Cardiac Insufficiency BIsoprolol Study in Japanese Patients With Chronic Heart Failure (CIBIS-J)

Chronic Heart Failure

Japan
PT Bio Farma

Recruiting

Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation Acute Coronary Syndrome (NSTEACS) Patients: a Multicenter, Non-randomized, Open-label, Non-inferiority Trial

Safety Issues | Effect of Drug

Indonesia
PT Bio Farma

Not yet recruiting

Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine

COVID-19
Faes Farma, S.A.

Completed

Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D Deficiency (WORFEROL)

Vitamin D Deficiency | Vitamin D Insufficiency

Spain, France, Bulgaria, Czechia, Italy, Serbia, Slovakia
PT Bio Farma

Completed

Protectivity and Safety Following Recombinant Hepatitis B Vaccine

Immunogenicity

Indonesia
PT Bio Farma

Completed

Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B

Safety | Immunogenicity

Indonesia
InnoUp Farma S.L.

Unknown

Oral Immunotherapy for Peanut Allergic Patients

Peanut Allergy

Spain
PT Bio Farma

Completed

Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children

Safety Issues | Immunogenicity

Indonesia
PT Bio Farma

Completed

Antibody Persistence, Immune Response and Safety After Doses of Pentabio Vaccine

Healthy

Indonesia
PT Bio Farma

Completed

Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma)

Healthy

Indonesia
PT Bio Farma

Completed

Safety of Hib Vaccine (Bio Farma)

Healthy

Indonesia
Faes Farma, S.A.

Completed

Efficacy Study for the Symptomatic Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Faes Farma, S.A.

Not yet recruiting

Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis.

Colitis, Ulcerative
Archivel Farma S.L.

Recruiting

Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis (CONSTAN-ARG)

Tuberculosis, Pulmonary

Argentina
Archivel Farma S.L.

Recruiting

Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)

Tuberculosis, Pulmonary

India
PT Bio Farma

Completed

Post Marketing Surveillance of Diphtheria Antitoxin (DAT)

Safety Issues

Indonesia
PT Bio Farma

Completed

Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children

Hepatitis B

Indonesia
PT Bio Farma

Completed

Safety Profile Following Inactivated COVID-19 Vaccine in Healthy Adults Aged >18 Years in Indonesia

Safety Issues

Indonesia
PT Bio Farma

Completed

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants

Safety Issues | Immunogenicity

Indonesia
PT Bio Farma

Completed

Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)

Measles | Congenital Rubella Infection

Indonesia
PT Bio Farma

Completed

Safety and Immunogenicity of Rotavirus (Bio Farma) Vaccine in Adults, Children & Neonates

Safety Issues

Indonesia
PT Bio Farma

Completed

Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population

Safety Issues

Indonesia
PT Bio Farma

Completed

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)

Safety Issues

Indonesia
PT Bio Farma

Completed

Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV

Healthy

Indonesia
PT Bio Farma

Completed

Immunogenocity and Safety of Flubio (Influenza HA) Vaccine in Infants and Children (Bridging Study)

Healthy

Indonesia
Faes Farma, S.A.

Completed

Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria

Urticaria

Argentina, Belgium, France, Germany, Poland, Romania, Spain
Faes Farma, S.A.

Completed

A Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the Electrocardiographic (ECG) Effects of Bilastine

Healthy

United States
PT Bio Farma

Completed

Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates

Rotavirus Gastroenteritis

Indonesia
PT Bio Farma

Completed

Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma)

Human Papilloma Virus Infection

Indonesia
PT Bio Farma

Completed

Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)

Safety Issues | Immunogenicity

Indonesia
PT Bio Farma

Completed

Safety Profile Following Pentabio Vaccination in Indonesian Infants

Healthy

Indonesia
PT Bio Farma

Completed

Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine

Healthy

Indonesia
PT Bio Farma

Completed

Protectivity and Safety of DTP/HB/Hib (Bio Farma) Vaccines in Infants, Batch Consistency, Multi Center Trial

Healthy

Indonesia
PT Bio Farma

Completed

The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma)

Healthy

Indonesia
Faes Farma, S.A.

Completed

Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)

Chronic Urticaria | Allergic Rhinoconjunctivitis

Australia, Germany, Sweden
Faes Farma, S.A.

Completed

Oral Bioavailability of Bilastine (BIOBI)

Healthy

Spain
Faes Farma, S.A.

Completed

Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety Extension

Perennial Allergic Rhinitis
Faes Farma, S.A.

Completed

A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine

Seasonal Allergic Rhinitis
Faes Farma, S.A.

Completed

A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Chamber

Seasonal Allergic Rhinitis

Austria
Redmond Fire Department Medic One
Medic One Foundation

Unknown

Randomized Trial of Prehospital Tropin Levels in Acute Coronary Syndrome (ACS)

Acute Coronary Syndrome

United States
IRIS Media Inc

Completed

ASD Parent Trainer: Online Coaching for Parents of Children With Autism (APT)

Autism Disorder

United States
MEDRx USA, Inc.

Completed

Etodolac-Lidocaine Patch in the Treatment of Acute Low Back Pain

Low Back Pain

United States
MEDRx USA, Inc.

Completed

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder

Bursitis | Acute Tendonitis

United States
MEDRx USA, Inc.

Completed

Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder

Shoulder Pain | Bursitis | Tendonitis

United States
Duke University
MEDEX

Terminated

AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19 (AirFLO2)

Hypoxia | Covid19 | Corona Virus Infection | Respiratory Rate

United States
MEDRx USA, Inc.

Completed

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains

Ankle Sprains

United States

3

Subscribe